Entry |
|
Name |
Eclitasertib (USAN/INN) |
Formula |
C19H18N6O3
|
Exact mass |
378.1440
|
Mol weight |
378.38
|
Structure |

|
Efficacy |
Antiviral, Autoimmune disease treatment |
Comment |
Treatment of COVID-19 and cutaneous lupus erythematosus
|
Target |
|
Pathway |
hsa04620 | Toll-like receptor signaling pathway |
hsa04621 | NOD-like receptor signaling pathway |
hsa04622 | RIG-I-like receptor signaling pathway |
|
Brite |
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
TKL group
RIPK1
D12352 Eclitasertib (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 28
1 C8x C 6.7200 -13.3700
2 C8x C 6.7200 -14.7700
3 N5x N 7.9100 -15.4700
4 C8y C 9.1700 -14.7700
5 C8y C 9.1700 -13.3700
6 C8x C 7.9100 -12.6700
7 O2x O 10.2900 -12.4600
8 C1x C 11.6200 -12.8100
9 C1y C 12.2500 -14.0700
10 C5x C 11.6200 -15.3300
11 N1y N 10.2900 -15.6100
12 C1a C 10.0100 -17.0100
13 O5x O 12.4600 -16.4500
14 N1b N 13.6500 -14.0700
15 C5a C 14.3500 -12.8800
16 C8y C 15.7500 -12.8800
17 N5x N 16.5900 -14.0000
18 C8y C 17.9200 -13.5800
19 N5x N 17.9200 -12.1800
20 N4x N 16.5900 -11.6900
21 O5a O 13.6500 -11.6900
22 C1b C 19.1100 -14.2800
23 C8y C 20.3000 -13.5800
24 C8x C 21.5181 -14.2701
25 C8x C 22.7248 -13.5603
26 C8x C 22.7834 -12.1603
27 C8x C 21.4953 -11.4702
28 C8x C 20.2886 -12.1800
BOND 31
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 8 9 1
8 9 10 1
9 7 8 1
10 4 11 1
11 5 7 1
12 10 11 1
13 11 12 1
14 10 13 2
15 9 14 1 #Down
16 14 15 1
17 15 16 1
18 16 17 2
19 17 18 1
20 18 19 2
21 19 20 1
22 16 20 1
23 15 21 2
24 18 22 1
25 22 23 1
26 23 24 2
27 24 25 1
28 25 26 2
29 26 27 1
30 27 28 2
31 23 28 1
|